论文部分内容阅读
癌症治疗的历史,突出的是被夸大了的希望和希望的落空。干扰素也被寄予了很大希望,其将来的结果是否完全令人失望,还有待观察。干扰素已经进行了一些无对照的化疗观察,并且积累了不少资料,因而寄予希望的范围也是个焦点问题。1979年Dunnick和Galasso在一篇干扰素临床研究的概述中,罗列了能对抗下列肿瘤:成骨肉瘤、多发性骨髓瘤、青年喉头乳头状瘤(Juvenile Lar-yngeal Papilloma)、颈部癌肿、乳腺癌、非何杰金氏淋巴瘤、黑色素瘤以及尖锐湿疣。每个实验结果都被确认是有益的。
The history of cancer treatment highlights the hopelessness and hopelessness that has been exaggerated. Interferon has also been given great hope. It remains to be seen whether its future results will be completely disappointing. Interferon has undergone some uncontrolled chemotherapy observations, and has accumulated a lot of information, so the range of hope is also a focus. In 1979, Dunnick and Galasso presented an overview of a clinical study of interferons that could counteract the following tumors: osteosarcoma, multiple myeloma, Juvenile Lar-yngeal Papilloma, neck cancer, Breast cancer, non-Hodgkin’s lymphoma, melanoma, and condyloma. Each experimental result was confirmed to be beneficial.